On August 23, 2024, the Food and Drug Administration (FDA) approved and authorized the 2024-2025 Moderna and Pfizer-BioNTech COVID-19 vaccines. The FDA reported that doses would start shipping immediately. Providers can order vaccines through their usual channels.
While the FDA has not deauthorized 2023-2024 COVID-19 Vaccines, the California Department of Public Health (CDPH) Immunization Program released a memo recommending that providers stop using 2023-2024 mRNA COVID-19 vaccines.
The 2023-2024 Novavax COVID-19 Vaccine remains authorized but is no longer available in the United States as all doses have expired. There are no recommendations for the use of Novavax COVID-19 Vaccine as no approved and authorized product exists at this time.
The CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States provides an up to date resource on the use of COVID-19 vaccines across the age spectrum. More info...
